Literature DB >> 18651847

Inflammatory response to chlorhexidine, minocycline HCl and doxycycline HCl in an in vivo mouse model.

Yael Houri-Haddad1, Amal Halabi, Wilfred Aubrey Soskolne.   

Abstract

AIM: To examine the effect of locally delivered antimicrobial drugs on the inflammatory response in an in vivo mouse chamber model.
MATERIAL AND METHODS: Two weeks following chamber implantation, 24 BALB/c mice, in the experimental group, were given an intra-chamber challenge of heat-killed Porphyromonas gingivalis, followed immediately by injection of the specific antimicrobial drug: 2000 microg/ml chlorhexidine (CHX); 1500 microg/ml minocycline HCl;and 1500 microg/ml doxycycline HCl (concentrations achieved in the periodontal pocket with commercial controlled-release delivery systems). A second group of 24 animals received only the antimicrobial treatment without P. gingivalis challenge. Intra-chamber exudates were sampled at 2 and 24 h following the challenge, and leucocytes, TNFalpha, IFNgamma and IL-10 were evaluated.
RESULTS: At 2 h, minocycline HCl induced high levels of IL-10, TNFalpha and IFNgamma, while CHX reduced the levels of TNFalpha and IFNgamma. By 24 h, these responses were attenuated. Following bacterial challenge, the antibacterial agents attenuated the inflammatory process, each in its own fashion.
CONCLUSIONS: Antibacterial agents applied locally have the ability to induce an inflammatory response. They also modify the inflammatory response to P. gingivalis independent of their antimicrobial effect. CHX and doxycycline HCl appear to have the most marked anti-inflammatory effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651847     DOI: 10.1111/j.1600-051X.2008.01290.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity.

Authors:  J Hua; R W Scott; G Diamond
Journal:  Mol Oral Microbiol       Date:  2010-12       Impact factor: 3.563

2.  Doxycycline's effect on ocular angiogenesis: an in vivo analysis.

Authors:  Constance A Cox; Juan Amaral; Rita Salloum; Liliana Guedez; Ted W Reid; Cindy Jaworski; Moly John-Aryankalayil; Ken A Freedman; Mercedes M Campos; Alfredo Martinez; Susan P Becerra; Deborah A Carper
Journal:  Ophthalmology       Date:  2010-06-03       Impact factor: 12.079

3.  Effects of Monolaurin on Oral Microbe-Host Transcriptome and Metabolome.

Authors:  Viviam de Oliveira Silva; Luciano José Pereira; Silvana Pasetto; Maike Paulino da Silva; Jered Cope Meyers; Ramiro Mendonça Murata
Journal:  Front Microbiol       Date:  2018-11-06       Impact factor: 5.640

4.  A New Controlled-Release Material Containing Metronidazole and Doxycycline for the Treatment of Periodontal and Peri-Implant Diseases: Formulation and In Vitro Testing.

Authors:  Livia Nastri; Alfredo De Rosa; Vincenza De Gregorio; Vincenzo Grassia; Giovanna Donnarumma
Journal:  Int J Dent       Date:  2019-03-05

5.  Efficacy of Xanthan-Based Chlorhexidine Gel on the Levels of Interleukin-1β in Chronic Periodontitis: An Interventional Study.

Authors:  H R Sajna; Amitha Ramesh; Madhurya N Kedlaya; Biju Thomas
Journal:  J Int Soc Prev Community Dent       Date:  2021-07-30

6.  Silver Nanoparticles as Chlorhexidine and Metronidazole Drug Delivery Platforms: Their Potential Use in Treating Periodontitis.

Authors:  Karol P Steckiewicz; Piotr Cieciórski; Ewelina Barcińska; Maciej Jaśkiewicz; Magdalena Narajczyk; Marta Bauer; Wojciech Kamysz; Elżbieta Megiel; Iwona Inkielewicz-Stepniak
Journal:  Int J Nanomedicine       Date:  2022-02-02

7.  Treatment modalities and evaluation models for periodontitis.

Authors:  Mohammad Tariq; Zeenat Iqbal; Javed Ali; Sanjula Baboota; Sushama Talegaonkar; Zulfiqar Ahmad; Jasjeet K Sahni
Journal:  Int J Pharm Investig       Date:  2012-07

8.  Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections.

Authors:  Leighann Sherry; Emma Millhouse; David F Lappin; Colin Murray; Shauna Culshaw; Christopher J Nile; Gordon Ramage
Journal:  BMC Oral Health       Date:  2013-09-24       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.